Malignancy in Idiopathic Inflammatory Myopathies: Recent Insights

Area of Science:

• Rheumatology
• Oncology
• Immunology

Background:

• Idiopathic inflammatory myopathies (IIMs) are rare autoimmune disorders.
• Certain IIM subtypes, like dermatomyositis (DM), are linked to elevated malignancy risk.
• The interplay between IIM pathogenesis and co-occurring cancers remains unclear.

Purpose of the Study:

• To review risk and protective factors for cancer-associated myositis (CAM).
• To provide insights into CAM pathogenesis, screening, and management.
• To identify future research directions and potential breakthroughs.

Main Methods:

• Literature review of existing evidence on risk factors for CAM.
• Analysis of myositis-specific or myositis-associated autoantibodies (MSAs/MAAs) in CAM.
• Exploration of heterogeneity in tumorigenesis across IIM subtypes.

Main Results:

• Growing evidence identifies specific risk factors for CAM, including MSAs/MAAs.
• Heterogeneity in tumorigenesis exists among different IIM subtypes.
• Current understanding of CAM pathogenesis requires further investigation.

Conclusions:

• Further research into CAM pathogenesis is essential for developing novel biomarkers and therapies.
• Understanding risk factors can improve screening and management strategies for CAM.
• Addressing knowledge gaps may lead to significant breakthroughs in CAM treatment.